The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom

Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gema Requena, John Logie, Daniel C. Gibbons, Jonathan Steinfeld, Melissa K. Van Dyke
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/bb846459b2d146bca141be52aa8e96d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb846459b2d146bca141be52aa8e96d5
record_format dspace
spelling oai:doaj.org-article:bb846459b2d146bca141be52aa8e96d52021-11-12T19:57:15ZThe increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom2050-452710.1002/iid3.495https://doaj.org/article/bb846459b2d146bca141be52aa8e96d52021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.495https://doaj.org/toc/2050-4527Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The patients of interest were identified using medical codes specific for HES. Annual incidence rates and prevalence were estimated for the years 2010–2018 (inclusive) using patients observed for a minimum period of one year. Results Between 2010 and 2018, 93 patients were identified with HES. During the study period the incidence of HES ranged from less than 0.04, 95% confidence interval (CI) (0.01–0.07) to 0.17, 95% CI (0.10–0.26) per 100,000 person‐years and the prevalence ranged from 0.15, 95% CI (0.10–0.25) to 0.89, 95% CI (0.74–1.09) cases per 100,000 persons. Sensitivity analyses varying the minimum observation period required to identify HES patients gave similar results. Conclusion These results provide estimates of the burden of HES in the United Kingdom and indicate that whilst HES is a very rare disease, there is evidence that is increasingly being recorded in UK primary care.Gema RequenaJohn LogieDaniel C. GibbonsJonathan SteinfeldMelissa K. Van DykeWileyarticlehypereosinophilic syndromeincidenceprevalenceUnited KingdomImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1447-1451 (2021)
institution DOAJ
collection DOAJ
language EN
topic hypereosinophilic syndrome
incidence
prevalence
United Kingdom
Immunologic diseases. Allergy
RC581-607
spellingShingle hypereosinophilic syndrome
incidence
prevalence
United Kingdom
Immunologic diseases. Allergy
RC581-607
Gema Requena
John Logie
Daniel C. Gibbons
Jonathan Steinfeld
Melissa K. Van Dyke
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
description Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The patients of interest were identified using medical codes specific for HES. Annual incidence rates and prevalence were estimated for the years 2010–2018 (inclusive) using patients observed for a minimum period of one year. Results Between 2010 and 2018, 93 patients were identified with HES. During the study period the incidence of HES ranged from less than 0.04, 95% confidence interval (CI) (0.01–0.07) to 0.17, 95% CI (0.10–0.26) per 100,000 person‐years and the prevalence ranged from 0.15, 95% CI (0.10–0.25) to 0.89, 95% CI (0.74–1.09) cases per 100,000 persons. Sensitivity analyses varying the minimum observation period required to identify HES patients gave similar results. Conclusion These results provide estimates of the burden of HES in the United Kingdom and indicate that whilst HES is a very rare disease, there is evidence that is increasingly being recorded in UK primary care.
format article
author Gema Requena
John Logie
Daniel C. Gibbons
Jonathan Steinfeld
Melissa K. Van Dyke
author_facet Gema Requena
John Logie
Daniel C. Gibbons
Jonathan Steinfeld
Melissa K. Van Dyke
author_sort Gema Requena
title The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
title_short The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
title_full The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
title_fullStr The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
title_full_unstemmed The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
title_sort increasing incidence and prevalence of hypereosinophilic syndrome in the united kingdom
publisher Wiley
publishDate 2021
url https://doaj.org/article/bb846459b2d146bca141be52aa8e96d5
work_keys_str_mv AT gemarequena theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT johnlogie theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT danielcgibbons theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT jonathansteinfeld theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT melissakvandyke theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT gemarequena increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT johnlogie increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT danielcgibbons increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT jonathansteinfeld increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
AT melissakvandyke increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom
_version_ 1718430339162963968